Prednisolone and Application site rash - a phase IV clinical study of FDA data
Application site rash is reported only by a few people who take Prednisolone.
The phase IV clinical study analyzes which people take Prednisolone and have Application site rash. It is created by eHealthMe based on reports of 180,802 people who have side effects while taking Prednisolone from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
180,802 people reported to have side effects when taking Prednisolone.
Among them, 5 people (0.0%) have Application site rash.
What is Prednisolone?
Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 182,032 Prednisolone users for its effectiveness, alternative drugs and more.
What is Application site rash?
Application site rash is found to be associated with 875 drugs and 593 conditions by eHealthMe.
Number of Prednisolone and Application site rash reports submitted per year:
Gender of people who have Application site rash when taking Prednisolone *:
- female: 100 %
- male: 0.0 %
Age of people who have Application site rash when taking Prednisolone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 33.33 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 66.67 %
Common drugs people take besides Prednisolone *:
- Duragesic-100: 2 people, 40.00%
- Viracept: 1 person, 20.00%
- Truvada: 1 person, 20.00%
- Bisacodyl: 1 person, 20.00%
- Celecoxib: 1 person, 20.00%
- Citalopram Hydrobromide: 1 person, 20.00%
- Clonidine: 1 person, 20.00%
- Cymbalta: 1 person, 20.00%
- Diazepam: 1 person, 20.00%
- Eprex: 1 person, 20.00%
Common side effects people have besides Application site rash *:
- Application Site Pruritus (application site severe itching of the skin): 3 people, 60.00%
- Application Site Pain: 2 people, 40.00%
- Application Site Vesicles (small bubble within a cell at application site): 2 people, 40.00%
- Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 20.00%
- Drowsiness: 1 person, 20.00%
- Application Site Erythema (redness of the skin at application site): 1 person, 20.00%
- Consciousness - Decreased: 1 person, 20.00%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 20.00%
- Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 20.00%
- Drug Effect Decreased: 1 person, 20.00%
Common conditions people have *:
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 20.00%
- Pain: 1 person, 20.00%
- Muscle Disorder (muscle disease): 1 person, 20.00%
- Inflammation: 1 person, 20.00%
- Hiv Infection: 1 person, 20.00%
- High Blood Pressure: 1 person, 20.00%
- Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 20.00%
- Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 1 person, 20.00%
- Bipolar Disorder (mood disorder): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Prednisolone and have Application site rash?Check whether Application site rash is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
How severe was Application site rash and when was it recovered:
Expand to all the drugs that have ingredients of prednisolone:
Alternative drugs to, pros and cons of Prednisolone:
- Prednisolone (182,032 reports)
Common Prednisolone side effects:
- Fever: 10,764 reports
- Pneumonia: 9,340 reports
- Drug ineffective: 8,974 reports
- Diarrhea: 7,028 reports
- Breathing difficulty: 7,011 reports
- Rashes (redness): 6,528 reports
- Thrombocytopenia (decrease of platelets in blood): 6,390 reports
Browse all side effects of Prednisolone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Application site rash treatments and more:
- Application site rash (13,034 reports)
COVID vaccines that are related to Application site rash:
- Application site rash in Moderna COVID Vaccine
- Application site rash in Pfizer BioNTech Covid Vaccine
- Application site rash in Johnson and Johnson Covid Vaccine
Common drugs associated with Application site rash:
- Butrans: 2,923 reports
- Nicoderm cq: 914 reports
- Rogaine: 378 reports
- Duragesic: 372 reports
- Zecuity: 371 reports
- Daytrana: 363 reports
- Nicotine: 334 reports
- Oxytrol for women: 314 reports
- Duragesic-100: 274 reports
- Climara: 263 reports
All the drugs that are associated with Application site rash:
- Application site rash (875 drugs)
Common conditions associated with Application site rash:
- Pain: 1,419 reports
- Quit smoking: 774 reports
- High blood pressure: 491 reports
- Back pain: 385 reports
- Hormone replacement therapy: 348 reports
All the conditions that are associated with Application site rash:
- Application site rash (593 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Renflexis and Cystitis Aggravated - now
- Finasteride and Unisom drug interaction - 3 seconds ago
- Aggrastat and Infusion Site Haematoma - 6 seconds ago
- Aggrenox and Xanax drug interaction - 8 seconds ago
- Meloxicam and Xanax drug interaction - 10 seconds ago
- Xanax and Neosar drug interaction - 11 seconds ago
- Rinvoq and Respiratory Acidosis - 13 seconds ago
- Nystatin and Tofacitinib drug interaction - 18 seconds ago
- Simbrinza and Urinary Retention - 20 seconds ago
- Macrobid and Neck Pain - 22 seconds ago